title: Remission of hormone-refractory prostate cancer attributed to Essiac.
abstract: Essiac is a popular complementary and alternative medicine (CAM) that is utilized by many cancer patients in North America. Much anecdotal reporting exists about its cancer-fighting qualities, but so far no clinical trials have been preformed to validate those claims. We describe here the case of a 64-year-old man whose hormone-refractory prostate cancer responded well to Essiac tea.
authors.affiliation: Division of Urology, The Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Wigdan
authors.initials: W
authors.lastname: Al-Sukhni
authors.forename: Ami
authors.initials: A
authors.lastname: Grunbaum
authors.forename: Neil
authors.initials: N
authors.lastname: Fleshner
mesh_terms: D006801:Humans; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012074:Remission Induction
chemical_list: C111756:Essiac; D010936:Plant Extracts